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http://dx.doi.org/10.1016/j.asjsur.20Summary Infection of a vascular prosthesis after a bypass surgery is relatively rare. However,
once developed, serious complications can occur, such as bleeding, sepsis, and organ ischemia,
occasionally resulting in leg amputation or even death in some cases. The treatment of a
vascular prosthesis infection involves the necessary removal of the infected graft; subse-
quently, an extra-anatomical bypass surgery is often considered. We herein report a case in
which postoperative methicillin-resistant Staphylococcus aureus infection caused dehiscence
of the femoral vessels and exposure of the graft vessel and anastomosed area. The infected tis-
sue was surgically removed (debridement), and the patient’s condition was successfully treated
by the application of a nonadherent dressing and vacuum-assisted closure therapy combined
with the bridging technique.
Copyright ª 2013, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.declare that they have no
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13.07.0011. Introduction
Infection of a vascular prosthesis following a bypass surgery
is relatively rare (0.92e6.4%). However, once developed,
serious complications can occur, such as bleeding, sepsis,
and organ failure, resulting in leg amputation (10e70%) or
even death (10e20%).1e4by Elsevier Taiwan LLC. All rights reserved.
VAC for MRSA-infected prosthetic graft 47The treatment of a vascular prosthesis infection involves
the necessary removal of the infected graft and then
draining pus from the infected site (abscess). A subsequent
extra-anatomical bypass surgery is often considered. Pre-
viously published reports suggest that graft preservation is
possible in cases satisfying the following requirements: (1)
absence of infection at the entire site of the graft; (2)
absence of signs of sepsis; (3) patency of the unaffected
parts of the graft; and (4) absence of Pseudomonas aeru-
ginosa infection.2,5 Various reports have shown that
vascular prosthesis was successfully preserved using a
vacuum-assisted closure system (VAC; KCI, San Antonio, TX,
USA).6e8 We herein report a case in which methicillin-
resistant Staphylococcus aureus (MRSA) infection following
femoropopliteal artery bypass surgery caused dehiscence of
the femoral and popliteal wounds and exposure of the
graft. In this case, we successfully preserved the graft using
a nonadherent dressing and a VAC system combined with
the bridging technique.2. Case report
A 59-year-old man underwent a common femoral-to-above-
knee popliteal artery bypass with a Dacron graft for the
treatment of critical limb ischemia with first toe necrosis.
An antibiotic (cefazolin) was administered by drip infusion
30 minutes prior to and 3 hours after the operation. He had
a history of diabetes mellitus and had been receiving
maintenance hemodialysis for the past 2 years. The patient
had undergone coronary artery bypass surgery 1 month
earlier. Three days after the bypass surgery, he developed a
spike fever (>38C). On the 8th postoperative day, pus
discharge was observed from the femoral wound and the
popliteal region that was accompanied by redness and pain
in the femoral region to the flank. White blood cell count
and C-reactive protein level were higher than normal limits
(18,000/mL and 28.09 mg/dL, respectively). The following
day, the femoral and popliteal wounds were exposed in the
operating room. On exposing the graft, a massive milky
white pus discharge was noted, which was accompanied in
both regions by macroscopically visible poor granulation
with wound infection (Fig. 1). Results of computedFigure 1 Macroscopically visible poor granulation and signs
of infection observed on the 9th postoperative day.tomography scans did not reveal any abscess in the subcu-
taneous tunnel of the femoral region along the vascular
prosthesis; therefore, the prosthesis was not removed.
Instead, debridement was performed, and to begin the
therapy, a VAC GranuFoam dressing (KCI) of a size to match
that of the wound was inserted into the femoral and
popliteal regions. During this insertion, the prosthesis was
covered with a nonadherent dressing in order to avoid
direct contact of the GranuFoam dressing with the pros-
thesis and the anastomosed area, as described by Dosluoglu
et al.5 The GranuFoam dressing (KCI) in the femoral wound
was connected to that in the popliteal wound using the
bridging technique,9 followed by the serial application of
negative pressure (125 mmHg; Fig. 2).
Incubation of the specimens from the wounds at the
femoral and popliteal sites revealed MRSA infection. How-
ever, the blood culture was negative for MRSA infection.
Vancomycin (VCM) treatment was initiated after the
detection of pus discharge from the wound, given the
possibility of MRSA infection. After the MRSA infection in
the graft-exposed area was confirmed, VCM treatment was
switched with linezolid. In subsequent cultures, MRSA was
detected until the 16th postoperative day, and Klebsiella
pneumoniae was isolated from the femoral site on the 25th
postoperative day. The final culture at the time of the
wound closure on the 46th postoperative day was negative.
Because the patient did not show clinical signs of infectionFigure 2 The GranuFoam dressing in the femoral wound is
connected to that in the popliteal wound using the bridging
technique to avoid direct exposure of the intact skin to the
negative pressure.
48 Y. Hisata et al.aggravation, the GranuFoam dressing (KCI) for VAC therapy
was renewed every week, and the popliteal wound was
closed during the 2nd week of VAC therapy. In the 5th week,
the wound showed macroscopically healthy granulation;
therefore, the patient was weaned from VAC therapy, and
the femoral wound was closed. Antibiotics were adminis-
tered for 2 months after the bypass surgery. Currently,
approximately 7 months after wound closure, the patient
has been free of wound abnormalities and shows no signs of
reinfection.
3. Discussion
Treatments usually performed in cases of vascular pros-
thesis infection include: (1) complete removal of the
prosthesis; (2) aggressive debridement; (3) cleansing to
reduce the bacterial count and to ensure sufficient blood
flow with granulation formation stimulation, use of a mus-
culocutaneous flap, and so on; and (4) long-term antibac-
terial drug treatment.5 However, removal of the graft
might cause ischemia, and an extra-anatomical bypass
surgery to avoid ischemia in such cases is often technically
difficult because of the low graft patency rate and the need
to avoid the infected area.
Despite serious concerns about using VAC therapy with
exposed grafts, many recent reports have described cases
that were completely cured by VAC therapy without
omental transposition or muscle flap closure while preser-
ving patency of the vascular prosthesis. Using this therapy,
a curing rate of 82% has been reported for the inguinal
region. Muscle flap closure was not used in the present case
because reinfection had been reported in 35% of cases
following this manipulation.6e8,10 The VAC therapy may be
considered the first choice of therapy for perivascular groin
infections, leading to a high rate of vascular graft recon-
struction preservation.7
Total and partial graft preservation has been reported in
42.5% and 35.8% of all cases, respectively, with a wound
healing rate of 85% and 71%, respectively. Much lower (40%)
success rates have been reported in cases in which P. aer-
uginosa was the cause of infection.2,5,11
The most commonly isolated bacterial species was
S. aureus (approximately 30%), including MRSA (12%).1,5 In
the present case, although MRSA was isolated, we applied
VAC therapy to observe its effects (bringing the wound
edges closer together, adjusting the wound environments,
reducing edema, and increasing blood flow around the
wound).12e14 In fact, VAC therapy was applied in a manner
similar to that previously reported.5e7,9,15
In the present case, we had the impression that the
therapy stimulated the process of granulation tissue for-
mation similar to the observation reported by Colwell
et al.16 However, considering the reports on bleeding and
pseudoaneurysms observed after VAC therapy for exposed
vascular grafts,7,8,10e13 adequate care during therapy and
further data collection are needed.References
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